Literature DB >> 18725236

Neurobiological substrates for the dark side of compulsivity in addiction.

George F Koob1.   

Abstract

Drug addiction can be defined by a compulsion to seek and take drug, loss of control in limiting intake, and the emergence of a negative emotional state when access to the drug is prevented. Drug addiction impacts multiple motivational mechanisms and can be conceptualized as a disorder that progresses from impulsivity (positive reinforcement) to compulsivity (negative reinforcement). The construct of negative reinforcement is defined as drug taking that alleviates a negative emotional state. The negative emotional state that drives such negative reinforcement is hypothesized to derive from dysregulation of key neurochemical elements involved in reward and stress within the basal forebrain structures involving the ventral striatum and extended amygdala. Specific neurochemical elements in these structures include not only decreases in reward neurotransmission, such as decreases in dopamine and opioid peptide function in the ventral striatum, but also recruitment of brain stress systems, such as corticotropin-releasing factor (CRF), in the extended amygdala. Acute withdrawal from all major drugs of abuse produces increases in reward thresholds, increases in anxiety-like responses, and increases in extracellular levels of CRF in the central nucleus of the amygdala. CRF receptor antagonists also block excessive drug intake produced by dependence. A brain stress response system is hypothesized to be activated by acute excessive drug intake, to be sensitized during repeated withdrawal, to persist into protracted abstinence, and to contribute to the compulsivity of addiction. Other components of brain stress systems in the extended amygdala that interact with CRF and may contribute to the negative motivational state of withdrawal include norepinephrine, dynorphin, and neuropeptide Y. The combination of loss of reward function and recruitment of brain stress systems provides a powerful neurochemical basis for a negative emotional state that is responsible for the negative reinforcement driving, at least in part, the compulsivity of addiction.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18725236      PMCID: PMC2637927          DOI: 10.1016/j.neuropharm.2008.07.043

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  132 in total

1.  Alpha 1-noradrenergic system role in increased motivation for cocaine intake in rats with prolonged access.

Authors:  Sunmee Wee; Chitra D Mandyam; Dusan M Lekic; George F Koob
Journal:  Eur Neuropsychopharmacol       Date:  2007-10-24       Impact factor: 4.600

2.  Effects of D-amphetamine on concurrent self-stimulation of forebrain and brain stem loci.

Authors:  G F Koob; G D Winger; J L Meyerhoff; Z Annau
Journal:  Brain Res       Date:  1977-11-25       Impact factor: 3.252

3.  Dramatic decreases in brain reward function during nicotine withdrawal.

Authors:  M P Epping-Jordan; S S Watkins; G F Koob; A Markou
Journal:  Nature       Date:  1998-05-07       Impact factor: 49.962

4.  Postcocaine anhedonia. An animal model of cocaine withdrawal.

Authors:  A Markou; G F Koob
Journal:  Neuropsychopharmacology       Date:  1991-01       Impact factor: 7.853

5.  Corticotropin releasing factor antagonist, alpha-helical CRF(9-41), reverses nicotine-induced conditioned, but not unconditioned, anxiety.

Authors:  Sonia Tucci; Survjit Cheeta; Pallab Seth; Sandra E File
Journal:  Psychopharmacology (Berl)       Date:  2003-04-01       Impact factor: 4.530

6.  Effect of aripiprazole, a partial dopamine D2 receptor agonist, on increased rate of methamphetamine self-administration in rats with prolonged session duration.

Authors:  Sunmee Wee; Zhixia Wang; William L Woolverton; Luigi Pulvirenti; George F Koob
Journal:  Neuropsychopharmacology       Date:  2007-02-28       Impact factor: 7.853

7.  Evidence for addiction-like behavior in the rat.

Authors:  Véronique Deroche-Gamonet; David Belin; Pier Vincenzo Piazza
Journal:  Science       Date:  2004-08-13       Impact factor: 47.728

8.  Microinjection of a corticotropin-releasing factor antagonist into the central nucleus of the amygdala reverses anxiogenic-like effects of ethanol withdrawal.

Authors:  S Rassnick; S C Heinrichs; K T Britton; G F Koob
Journal:  Brain Res       Date:  1993-03-05       Impact factor: 3.252

Review 9.  A role for brain stress systems in addiction.

Authors:  George F Koob
Journal:  Neuron       Date:  2008-07-10       Impact factor: 17.173

10.  Induction of chronic Fos-related antigens in rat brain by chronic morphine administration.

Authors:  H E Nye; E J Nestler
Journal:  Mol Pharmacol       Date:  1996-04       Impact factor: 4.436

View more
  187 in total

1.  Overexpression of CREB in the nucleus accumbens shell increases cocaine reinforcement in self-administering rats.

Authors:  Erin B Larson; Danielle L Graham; Rose R Arzaga; Nicole Buzin; Joseph Webb; Thomas A Green; Caroline E Bass; Rachael L Neve; Ernest F Terwilliger; Eric J Nestler; David W Self
Journal:  J Neurosci       Date:  2011-11-09       Impact factor: 6.167

Review 2.  Are executive function and impulsivity antipodes? A conceptual reconstruction with special reference to addiction.

Authors:  Warren K Bickel; David P Jarmolowicz; E Terry Mueller; Kirstin M Gatchalian; Samuel M McClure
Journal:  Psychopharmacology (Berl)       Date:  2012-03-24       Impact factor: 4.530

Review 3.  Chronic alcohol neuroadaptation and stress contribute to susceptibility for alcohol craving and relapse.

Authors:  George R Breese; Rajita Sinha; Markus Heilig
Journal:  Pharmacol Ther       Date:  2010-10-15       Impact factor: 12.310

Review 4.  Neuromodulation interventions for addictive disorders: challenges, promise, and roadmap for future research.

Authors:  Primavera A Spagnolo; David Goldman
Journal:  Brain       Date:  2017-05-01       Impact factor: 13.501

5.  Chronic nicotine activates stress/reward-related brain regions and facilitates the transition to compulsive alcohol drinking.

Authors:  Rodrigo M Leão; Fábio C Cruz; Leandro F Vendruscolo; Giordano de Guglielmo; Marian L Logrip; Cleopatra S Planeta; Bruce T Hope; George F Koob; Olivier George
Journal:  J Neurosci       Date:  2015-04-15       Impact factor: 6.167

6.  Central amygdala relaxin-3/relaxin family peptide receptor 3 signalling modulates alcohol seeking in rats.

Authors:  Leigh C Walker; Hanna E Kastman; Elena V Krstew; Andrew L Gundlach; Andrew J Lawrence
Journal:  Br J Pharmacol       Date:  2017-08-23       Impact factor: 8.739

7.  Differential involvement of anxiety and novelty preference levels on oral ethanol consumption in rats.

Authors:  Yann Pelloux; Jean Costentin; Dominique Duterte-Boucher
Journal:  Psychopharmacology (Berl)       Date:  2015-03-13       Impact factor: 4.530

Review 8.  Amygdalostriatal projections in the neurocircuitry for motivation: a neuroanatomical thread through the career of Ann Kelley.

Authors:  Eric P Zorrilla; George F Koob
Journal:  Neurosci Biobehav Rev       Date:  2012-12-07       Impact factor: 8.989

9.  A selective insular perfusion deficit contributes to compromised salience network connectivity in recovering alcoholic men.

Authors:  Edith V Sullivan; Eva Müller-Oehring; Anne-Lise Pitel; Sandra Chanraud; Ajit Shankaranarayanan; David C Alsop; Torsten Rohlfing; Adolf Pfefferbaum
Journal:  Biol Psychiatry       Date:  2013-04-12       Impact factor: 13.382

10.  The influences of reproductive status and acute stress on the levels of phosphorylated delta opioid receptor immunoreactivity in rat hippocampus.

Authors:  Suzanne R Burstein; Tanya J Williams; Diane A Lane; Margarete G Knudsen; Virginia M Pickel; Bruce S McEwen; Elizabeth M Waters; Teresa A Milner
Journal:  Brain Res       Date:  2013-04-11       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.